¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Asthma School 2018 : 2018-09-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Asthma School 2018 : 2018-09-08
±³À°ÀÏÀÚ : 2018-09-08
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 
±³À°ÁÖÁ¦ : Asthma School 2018     
ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : õ½Ä¿¬±¸È¸ 
´ã´çÀÚ : Á¤Çý¼±
¿¬¶ôó : 02-575-3825 
À̸ÞÀÏ : katrd@hanmail.net     
±³À°Á¾·ù : ³»°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡ 
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ 
¼¼ºÎ¼ö°­·á : 20,000¿ø     
ºñ°í »çÀüµî·Ï : 10,000¿ø/ ÇöÀåµî·Ï : 20,000¿ø     
      
±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 08ÀÏ °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 14:00~14:30 Asthma Guideline : 2018 Update  ¾ö¼öÁ¤(µ¿¾ÆÀÇ´ë ³»°ú)
±³À°½Ã°£ 09¿ù 08ÀÏ °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 14:30~15:00 Airway Remodeling in Asthma : Assessment, Treatment and Prevention  ±è¼Ò¸®(ÀüºÏÀÇ´ë ³»°ú)
±³À°½Ã°£ 09¿ù 08ÀÏ °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 15:00~15:30 Severe Exacerbation and Its Association with Specific Phenotypes in Asthma  ¹Ú¿ë¹ü(ÇѸ²ÀÇ´ë ³»°ú)
±³À°½Ã°£ 09¿ù 08ÀÏ °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 16:00~16:30 Asthma in Old Age : Difference from COPD  ÀÌÁø±¹(°¡Å縯ÀÇ´ë ³»°ú)
±³À°½Ã°£ 09¿ù 08ÀÏ °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 16:30~17:00 Focusing on Allergy : Allergen and Allergen-specific Immunotherapy in Asthma  ±èº´±Ù(°í·ÁÀÇ´ë ³»°ú)
±³À°½Ã°£ 09¿ù 08ÀÏ °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 17:00~17:30 Biological Therapies : Current Status and Controversial Issues  ¿À¿¬¸ñ(¿ï»êÀÇ´ë ³»°ú) 
»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 16:30~17:00 Focusing on Allergy : Allergen and Allergen-specific Immunotherapy in Asthma  ±èº´±Ù(°í·ÁÀÇ´ë ³»°ú) 
±³À°½Ã°£ 09¿ù 08ÀÏ °Ç±¹´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸µ¿ ÁöÇÏ 1Ãþ ´ë°­´ç 17:00~17:30 Biological Therapies : Current Status and Controversial Issues  ¿À¿¬¸ñ(¿ï»êÀÇ´ë ³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Asthma School 2018 : 2018-09-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æÈñ´ëÇб³º´¿ø ¹é¹ÝÁõ°ú »ö¼ÒÁúȯ : 2018-09-08
´ÙÀ½±Û 2018³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20835 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ 2024³â Á¦ 1ȸ ³»½Ã°æ Áý´ãȸ : 2024-06-21 0 26 2024-05-27
20834 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-21 0 8 2024-05-27
20833 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 1ÀÏÂ÷ : 2024-06-21 0 17 2024-05-27
20832 ¼­¿ï Á¦8Â÷ µµºÀ±¸ÀÇ»çȸ Çмú¼¼¹Ì³ª(½ÉÇ÷°üÁúȯ ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á, ºÒ¸éÁõ, Ä¡¸Å¾à¹°Ä¡·á, Ç×Ç÷ÀüÁ¦) : 2024-06-21 0 13 2024-05-27
20831 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2024-06-21 0 4 2024-05-27
20830 Á¦ÁÖ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-21 0 8 2024-05-27
20829 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(1ÀÏÂ÷) : 2024-06-20 0 4 2024-05-27
20828 ºÎ»ê ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2024-06-20 0 13 2024-05-27
20827 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 510ȸ ÇмúÁý´ãȸ : 2024-06-20 0 8 2024-05-27
20826 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (1ÀÏÂ÷) : 2024-06-20 0 5 2024-05-27
20825 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÅëÁõÇÐȸ ¼­¿ïÁöȸ Áý´ãȸ : 2024-06-20 0 5 2024-05-27
20824 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¼­½Ä ÀÛ¼º ½ÇÁ¦) : 2024-06-20 0 4 2024-05-27
20823 °æ±â µ¿±¹´ëÇб³ Àϻ꺴¿ø : °ñ°üÀý¿°ÀÇ Áø´Ü ¹× Ä¡·á : 2024-06-19 0 9 2024-05-27
20822 °æ±â ´ëÇÑ°£ÇÐȸ Overlooked Liver Diseases : 2024-06-19 0 15 2024-05-27
20821 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦2ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-06-17 0 26 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷